SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1011 quod erat demonstrandum. ----- <b>Biogen Announces 2-for-1 Stock Split&Beltropolis Boy-6/11/1999
1010 P.M. Your answer is nonresponsive. It was a simple question, calling for a simWilliam Partmann-6/10/1999
1009 PMF, your math works for the most part. $131MM to $300MM per quarter growth ovHarold Engstrom-6/10/1999
1008 Bill: I am not educating you but discussing with you and trying to learn from bP.M.Freedman-6/10/1999
1007 P.M., are you long, short, or just volunteering your time trying to educate us?William Partmann-6/9/1999
1006 Let's do a bit math. Assuming Biogen's claim came true in three years, P.M.Freedman-6/9/1999
1005 <i>A company who treasures its own stock for company's stock option Biomaven-6/9/1999
1004 A company who treasures its own stock for company's stock option plan can bP.M.Freedman-6/9/1999
1003 I stand corrected. You are absolutely right and you have studied this company JEB-6/9/1999
1002 <i>Those repurchased BGEN shares were still able to be accounted as BiogBiomaven-6/9/1999
1001 The "cash" reported in 10Q, as always, included Biogen's holdingsP.M.Freedman-6/9/1999
1000 They reported $612.4 Million in cash for 1st quarter. biz.yahoo.com Not a goJEB-6/9/1999
999 In February, Biogen announced a repurchase of 4 million shares of BGEN over theP.M.Freedman-6/9/1999
998 Nice NY Times article on Avonex and other MS drugs. Suggests to me that there&#Biomaven-6/8/1999
997 Thank you, William. That was a good report.Harold Engstrom-6/4/1999
996 Harold, here's Lehman Bros. take on recent events. lehman.comWilliam Partmann-6/4/1999
995 go, BGEN! go, IDPH! (if and when you can) go, RGEN! (anybody see that strangescaram(o)uche-6/3/1999
994 richard. a blurb on your rhesus pieces ... -chris. ----- <b>New drug Beltropolis Boy-6/3/1999
993 Upgrade ------------------ biz.yahoo.com ------------------ NEW YORK, June 1 (William Partmann-6/1/1999
992 BGEN: Positive Amevive Results; Raising Ests and Price Target Salomon Smith BaWilliam Partmann-5/29/1999
991 Harold, I think this has less to do with BGEN and more to do with the overall mJEB-5/28/1999
990 H&Q extract about Biogen. Not to sharp, especially in light of recent deveHarold Engstrom-5/28/1999
989 We're doing great in these market conditions. JEB-5/27/1999
988 RTQ @ 9:40 a.m. $110 even on 731,100 shares. apologies for the myopia.Beltropolis Boy-5/26/1999
987 Excuse me,...uh hem...YYYIIIIII HHHAAAAAAAA!, ...sorry, you may go about your bJEB-5/26/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News